Search details
1.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Front Oncol
; 13: 1212752, 2023.
Article
in English
| MEDLINE | ID: mdl-37427126
2.
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma.
Cancers (Basel)
; 14(17)2022 Aug 29.
Article
in English
| MEDLINE | ID: mdl-36077711
Results
1 -
2
de 2
1
Next >
>>